A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients.
Zheng X, Zhang W, Zhou H, Cao R, Shou Z, Zhang S, Cheng Y, Chen X, Ding C, Tang Z, Li N, Shi S, Zhou Q, Chen Q, Chen G, Chen Z, Zhou P, Hu X, Zhang X, Na N, Wang W.
Zheng X, et al.
Chin Med J (Engl). 2022 Jul 25;135(13):1597-603. doi: 10.1097/CM9.0000000000001866. Online ahead of print.
Chin Med J (Engl). 2022.
PMID: 35861301
Free PMC article.